Every Form 4 that Immatics N.V. (IMTX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IMTX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMTX filings page.
Immatics N.V. (IMTX) reported an insider Form 4 transaction related to Perceptive entities. On 2026-08-26, Perceptive Life Sciences Master Fund Ltd. purchased 863,060 Ordinary Shares of Immatics at $8.69 per share in an open-market or private transaction. After this purchase, the Master Fund's reported indirect holdings associated with the filing stood at 11,246,516 Ordinary Shares. The shares are directly held by the Master Fund, while Perceptive Advisors LLC serves as investment manager and Joseph Edelman is the managing member of the Advisor; both Edelman and the Advisor disclaim beneficial ownership except to the extent of any indirect pecuniary interest.
Immatics N.V. (IMTX) reported that officer James Nelson, General Counsel and Corporate Secretary, received equity-based compensation on August 14, 2026. He was granted a stock option for 181,200 ordinary shares at an exercise price of $9.44 per share, expiring on August 13, 2036, vesting 25% on August 14, 2027 and then in 12 equal quarterly installments over three years. He also received 43,800 restricted stock units, each representing one ordinary share, vesting in four equal annual installments on each anniversary of August 14, 2027. Following these grants, his reported holdings in these derivative awards are 181,200 option-linked shares and 43,800 RSU-linked shares, all held directly.
Immatics N.V. director Adam Leo Stone received a grant of stock options representing 48,000 Ordinary Shares. The options carry an exercise price of $9.09 per share and expire on June 15, 2036. According to the terms, these options vest 100% on the first anniversary of the grant date, on June 16, 2026. Following this grant, Stone holds 48,000 stock options directly as a compensation-related award rather than an open-market purchase.
Immatics N.V. director Alise Reicin reported a compensation-related award of stock options. She received 48,000 Stock Options (Right to Buy) to acquire Immatics ordinary shares.
The options carry an exercise price of $9.09 per share, expire on June 15, 2036, and vest 100% on June 16, 2026. Following this grant, Reicin holds 48,000 derivative securities of this type directly.
Immatics N.V. director Michael G. Atieh received a grant of stock options covering 48,000 underlying ordinary shares. The options have an exercise price of $9.09 per share, expire on June 15, 2036, and vest 100% on the first anniversary of the June 16, 2025 grant date.
Immatics N.V. director Carter Paul Rutherford received a grant of stock options covering 48,000 Ordinary Shares. The options have an exercise price of $9.09 per share and expire on June 15, 2036. According to the footnote, the options vest 100% on the first anniversary of the grant date, June 16, 2026. This is a compensation-related award, not an open-market share purchase or sale.
Immatics N.V. director Eliot Forster received a grant of stock options covering 48,000 ordinary shares. The options have an exercise price of $9.09 per share and expire on June 15, 2036. They vest 100% on the first anniversary of the grant date, June 16, 2026, and result in total option holdings of 48,000 derivative securities reported in this filing.
Immatics N.V. director Peter Alan Chambre received a grant of stock options as part of his compensation. He was awarded 48,000 Stock Options (Right to Buy), each allowing purchase of one ordinary share at an exercise price of $9.09 per share.
The options vest 100% on the first anniversary of the grant date, June 16, 2026, and expire on June 15, 2036. Following this award, his reported holdings in this option grant total 48,000 derivative securities, with no shares bought or sold in the market in this filing.
Immatics N.V. director Heather L. Mason received a grant of stock options as part of her compensation. She was awarded options to buy 48,000 ordinary shares at an exercise price of $9.09 per share. These options vest 100% on the first anniversary of the grant date, June 16, 2026, and expire on June 15, 2036. After this grant, she holds 48,000 stock options directly.
Immatics N.V. reported an insider equity award linked to its board of directors. Options covering 48,000 ordinary shares were granted on June 16, 2026 with an exercise price of $9.09 per share and expire on June 15, 2036.
The option vests in full on the first anniversary of the grant date. The award relates to director compensation for Adam Stone’s board service, and Perceptive Advisors LLC reports an indirect pecuniary interest through a management fee offset arrangement, while disclaiming beneficial ownership except to that indirect interest.
Immatics N.V. director Mathias Hothum received a grant of 48,000 stock options to purchase Ordinary Shares at an exercise price of $9.09 per share. These options vest 100% on June 16, 2026 and expire on June 15, 2036, leaving him holding 48,000 derivative securities directly.
This is a compensation-related award, not an open-market stock purchase or sale.